| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/20/2006 | US20060083738 Treatment of cancer by the use of anti fas antibody |
| 04/20/2006 | US20060083722 Methods and compositions for cell therapy |
| 04/20/2006 | US20060083718 Novel therapy for lysosomal enzyme deficiencies |
| 04/20/2006 | US20060083717 System and method for forming a non-ablative cardiac conduction block |
| 04/20/2006 | US20060083716 Composition for delivering an agent to a target cell and uses thereof |
| 04/20/2006 | US20060083684 Method of radio-labelling biomolecules |
| 04/20/2006 | DE19754938B4 TGC-Verfahren zur Induktion einer zielgerichteten, somatischen Transgenität TGC method for inducing a targeted somatic transgenic |
| 04/20/2006 | DE102005000868A1 Zusammensetzungen mit Inhibitoren der Prostaglandin- und/oder Leukotrien-Synthese in Kombination mit Stimulatoren der Freisetzung kutaner Neuromediatoren Compositions with inhibitors of prostaglandin and / or leukotriene synthesis in combination with stimulators of the release of cutaneous neuromediators |
| 04/20/2006 | DE10101761B4 Verwendung von isolierten homogenen Nukleinsäure-Multimeren für die nicht-virale Gentherapie oder genetische Impfung Use of isolated homogeneous nucleic acid multimers of the non-viral gene therapy or genetic vaccination |
| 04/20/2006 | CA2597341A1 Depression of herg k+ channel function in mammalian cells and applications to the control of cancer cells division |
| 04/20/2006 | CA2584878A1 Method and kit for detecting a risk of acute myocardial infarction |
| 04/20/2006 | CA2583361A1 Gene immunization using an antigen-chaperonin fusion |
| 04/20/2006 | CA2583243A1 Promotion of cell migration and axon regeneration in the cns |
| 04/20/2006 | CA2583147A1 Chimeric vectors |
| 04/20/2006 | CA2581632A1 Biodegradable cationic polymers |
| 04/19/2006 | EP1647292A1 Needleless syringe having medical agent accommodated therein |
| 04/19/2006 | EP1647188A2 A method of controlling fungal pathogens, and agents useful for same |
| 04/19/2006 | EP1646719A2 Nucleotides for prevention and treatment of bacterial and fungal pathologies |
| 04/19/2006 | EP1646717A2 Subgroup b adenoviral vectors for treating disease |
| 04/19/2006 | EP1646716A1 Yellow fever mosquito deoxyribonucleoside kinases and its use |
| 04/19/2006 | EP1646684A2 Polymer encapsulation of adenoviruses |
| 04/19/2006 | EP1646282A1 Genetic vaccines for cancer therapy |
| 04/19/2006 | EP1521523A4 Methods and compositions for delivering enzymes and nucleic acid molecules to brain, bone, and other tissues |
| 04/19/2006 | EP1228199B1 Method for directed packaging of molecular substances in protein shells |
| 04/19/2006 | EP1151102B1 Glycosylated leptin compositions and related methods |
| 04/19/2006 | EP1121381B1 Zinc finger binding domains for gnn |
| 04/19/2006 | EP1073760B1 Adenovirus mutants with deleted protease gene, complementing cell lines and corresponding vectors for gene transfer |
| 04/19/2006 | EP1039934B1 Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/19/2006 | EP0912608B1 Choline binding proteins for anti-pneumococcal vaccines |
| 04/19/2006 | EP0866873B1 Non-group c adenoviral vectors |
| 04/19/2006 | EP0812352B1 Redirection of cellular immunity by protein-tyrosine kinase chimeras |
| 04/19/2006 | EP0801575B1 Retroviral vectors for expression in embryonic cells |
| 04/19/2006 | EP0789574B1 Use of naked polynucleotides in the manufacture of a medicament for treating tumours |
| 04/19/2006 | CN1761757A Adeno-associated virus mediated B7.1 vaccination synergizes with angiostatin to eradicate disseminated liver metastatic cancers |
| 04/19/2006 | CN1761681A Regulation of gene expression |
| 04/19/2006 | CN1759888A Application scheme for treating injury of spinal cord by transplanting Olfactory essheathing cells |
| 04/19/2006 | CN1252274C Recombinant sendai virus vector for introducing exogenous gene to airway epithelia |
| 04/19/2006 | CN1252260C Tumor-specific promoters |
| 04/19/2006 | CN1251766C 肿瘤基因开关药物 Tumor gene switch drugs |
| 04/19/2006 | CN1251765C 肿瘤基因开关药物 Tumor gene switch drugs |
| 04/19/2006 | CN1251764C 肿瘤基因开关药物 Tumor gene switch drugs |
| 04/18/2006 | US7030292 Method for producing a population of homozygous stem cells having a pre-selected immunotype and/or genotype, cells suitable for transplant derived therefrom, and materials and methods using same |
| 04/18/2006 | US7030236 Antisense oligonucleotides tarageting folate receptor alpha, and the use thereof |
| 04/18/2006 | US7030222 Human gastric cancer antigen gene and gastric cancer antigen protein |
| 04/18/2006 | US7030219 Nucleotide sequences coding protein for use in treatment of cancer and prevention of viral infection |
| 04/18/2006 | US7030099 Tumor specific promoters of the midkine gene that allow for selective expression in P53-inactivated cells |
| 04/18/2006 | US7030098 DNA vaccination for treatment of autoimmune disease |
| 04/18/2006 | US7030096 transduction of DNA sequences by naked DNA transfer, expression of genes that code for muscle tone controllers; gene therapy for prophylaxis of erectile dysfunction, urogenital and muscular disorders |
| 04/18/2006 | US7030083 Prevention and treatment of endothelial injury and the injury of tissues containing injured blood vessels by administration of vascular endothelial cell growth factor |
| 04/18/2006 | US7029914 DNA encoding SNORF36 receptors |
| 04/18/2006 | US7029911 AFC1 and RCE1: isoprenylated CAAX processing enzymes |
| 04/18/2006 | US7029898 Comprises chimeric polypeptide with hydrolase and mitogen activated protein kinase activity for diagnosis and treatment of cell proliferation and differentiation disorders |
| 04/18/2006 | US7029895 Comprises nucleotide sequences coding cardiolipin for diagnosis and treatment of lung, heart and respiratory disorders |
| 04/18/2006 | US7029859 Sequences for targeting metastatic cells |
| 04/18/2006 | US7029848 High throughput screening of gene function using libraries for functional genomics applications |
| 04/18/2006 | US7029838 Generating vasculaized tissue; obtain prevascularized graft, mix with sample tissue, propagate tissue, recover vascularized tissue |
| 04/18/2006 | US7029681 Multiple and multivalent DNA vaccines in ovo |
| 04/18/2006 | US7029668 Endothelium gene expression opf core protein; Dna sequences; transfection; binding to heparan sulfate |
| 04/18/2006 | US7029666 Uses for non-autologous mesenchymal stem cells |
| 04/18/2006 | US7029665 Human suppressor tRNA oligonucleotides and methods for use for same |
| 04/18/2006 | US7029664 Chicken leukemia inhibitory factor (LIF) |
| 04/13/2006 | WO2006073458A2 Oligonucleotides comprising a c5-modified pyrimidine |
| 04/13/2006 | WO2006039399A2 Staufen 1 (stau1) - mediated mrna decay |
| 04/13/2006 | WO2006039343A2 Emmprin antagonists and uses thereof |
| 04/13/2006 | WO2006038729A1 Mutated amyloid protein |
| 04/13/2006 | WO2006010515A3 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 2a receptor (5ht2a) |
| 04/13/2006 | WO2005121372A3 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 04/13/2006 | WO2005116192A3 Genetically engineered cells for therapeutic applications |
| 04/13/2006 | WO2005112997A3 Composition and method for introduction of dna directed or direct rna interference sequence into targeted cells and tissues |
| 04/13/2006 | WO2005100576A3 Replication competent viruses capable of silencing virus inhibitory factor expression |
| 04/13/2006 | WO2005099763A3 Composition for intracellular transfer of a nucleic acid |
| 04/13/2006 | WO2005056806A3 Viral vectors controlled by a gene switch |
| 04/13/2006 | WO2005002507A3 Modulation of survivin expression |
| 04/13/2006 | US20060080744 Novel chemokine-like polypeptides |
| 04/13/2006 | US20060079672 Kits for modulating angiogenesis |
| 04/13/2006 | US20060079670 98 human secreted proteins |
| 04/13/2006 | US20060079477 High affinity nucleic acid ligands of complement system proteins |
| 04/13/2006 | US20060079476 Method for enhancing production of isoprenoid compounds |
| 04/13/2006 | US20060079475 Methods and compositions for modulating cardiac contractility |
| 04/13/2006 | US20060079474 Analogs of tRNA synthetase fragments and uses thereof |
| 04/13/2006 | US20060079473 Multi-unit complexes and uses thereof |
| 04/13/2006 | US20060079472 Methods for treating angiogenesis |
| 04/13/2006 | US20060079471 Snornai-small nucleolar rna degradation by rna interference in trypanosomatids |
| 04/13/2006 | US20060079470 Combined dna vaccine and biological modifiers for cancer therapy |
| 04/13/2006 | US20060079469 Anti-restenosis agent |
| 04/13/2006 | US20060079453 Hla binding peptides and their uses |
| 04/13/2006 | US20060079449 Inhibition of Smad3 to prevent fibrosis and improve wound healing |
| 04/13/2006 | US20060079443 Methods and uses of leptin in immune modulation |
| 04/13/2006 | US20060079442 Methods and uses of leptin in immune modulation and hepatocellular carcinoma |
| 04/13/2006 | US20060079441 Methods of modulating angiogenesis |
| 04/13/2006 | US20060079439 Elastin prevents occlusion of body vessels by vascular smooth muscle cells |
| 04/13/2006 | US20060078996 Surface transfection and expression procedure |
| 04/13/2006 | US20060078956 Methods to identify compounds that modulate rage |
| 04/13/2006 | US20060078940 21132, a human G-protein coupled receptor family member and uses therefor |
| 04/13/2006 | US20060078901 Listeria monocytogenes genome, polypeptides and uses |
| 04/13/2006 | US20060078879 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications |
| 04/13/2006 | US20060078878 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |
| 04/13/2006 | US20060078558 Diagnosis, prognosis and treatment of pulmonary diseases |
| 04/13/2006 | US20060078552 Hybrid and single chain meganucleases and use thereof |
| 04/13/2006 | US20060078545 Neural progenitor cell populations |